HarBin Medical Univ. c-Myc G-quadruplex compound W11

HarBin Medical Univ. c-Myc G-quadruplex compound W11: sourced facts only. name: "Finally, compound W11 was identified as the compound skeleton which has the potential to target c-Myc G4." [PMID:40262296]; target: "Finally, compound W11 was identified as the compound skeleton which has the potential to target c-Myc G4." [PMID:40262296]; developer: "Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, Harbin, 150081, China." [PMID:40262296]; stage: "Cell experiments and MCF-7 tumor xenograft experiments demonstrated that W11 inhibited the proliferation and metastasis of breast cancer cells by downregulating the transcription and translation of the c-Myc gene." [PMID:40262296]